Result Unit
Reference:
| AP (Alk
Phos)............................................................... |
30 to 120 U/L |
| GGT (Gamma
GT)........................................................ |
5 to 35 U/L |
| LD Lactate
Dehydrogenase......................................... |
100 to 225 U/L |
| AST
(Aspartate
aminotransferase)............................... |
5 to 45 U/L |
| ALT (Alanine aminotransferase).................................. |
5 to 45 U/L |
| Albumin....................................................................... |
38-55 g/L |
| Total
Bilirubin-Normal range is 3
- 18 umol/L.............. |
.0.174 - 1.04mg/dL |
| Clotting Studies (Prothrombin
Time)........................... |
1 to 13.5 Seconds |
Clinical Study (1989)
Long-term treatment with silymarin
significantly increased survival
rates in a randomized, double-blind,
placebo-controlled study of 105
people with cirrhosis.
Subjects took
either 420 mg of silymarin daily or
placebo during the study, which
lasted for approximately 41 months.
Over a 4-year period, the mortality
rate in the placebo group was twice
that of the
silymarin group.
Silymarin showed the greatest
benefit in those with
alcohol-related cirrhosis. There
appeared to be no difference in the
results of liver function tests
(transminases, bilirubin, SGGPT, and
other liver enzymes) between the two
groups. No side effects were
reported.
|